Invention Grant
- Patent Title: Compounds having α4β7 integrin inhibition activity
-
Application No.: US18068657Application Date: 2022-12-20
-
Publication No.: US11957761B2Publication Date: 2024-04-16
- Inventor: Stefan Schunk
- Applicant: Zealand Pharma A/S
- Applicant Address: DK Søborg
- Assignee: Zealand Pharma A/S
- Current Assignee: Zealand Pharma A/S
- Current Assignee Address: DK Søborg
- Agency: MARSHALL, GERSTEIN & BORUN LLP
- Priority: EP 216012.1 2021.12.20 EP 201323.7 2022.10.13 TW 1148705 2022.12.19
- Main IPC: A61K47/64
- IPC: A61K47/64 ; A61K47/54 ; A61P1/12 ; A61P29/00
Abstract:
Compounds of formula (1):
and pharmaceutically acceptable salts and solvates thereof, are described. The compounds are α4β7 antagonists and are useful in the prevention or treatment of inflammatory conditions and/or autoimmune diseases, especially inflammatory bowel disease.
and pharmaceutically acceptable salts and solvates thereof, are described. The compounds are α4β7 antagonists and are useful in the prevention or treatment of inflammatory conditions and/or autoimmune diseases, especially inflammatory bowel disease.
Public/Granted literature
- US20230190946A1 COMPOUNDS Public/Granted day:2023-06-22
Information query
IPC分类:
